Nagahisa A - Search Results

1

Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.

Boyer SH, Ugarkar BG, Solbach J, Kopcho J, Matelich MC, Ollis K, Gomez-Galeno JE, Mendonca R, Tsuchiya M, Nagahisa A, Nakane M, Wiesner JB, Erion MD. Boyer SH, et al. Among authors: nagahisa a. J Med Chem. 2005 Oct 6;48(20):6430-41. doi: 10.1021/jm0503650. J Med Chem. 2005. PMID: 16190769

2

Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.

Bookser BC, Ugarkar BG, Matelich MC, Lemus RH, Allan M, Tsuchiya M, Nakane M, Nagahisa A, Wiesner JB, Erion MD. Bookser BC, et al. Among authors: nagahisa a. J Med Chem. 2005 Dec 1;48(24):7808-20. doi: 10.1021/jm050394a. J Med Chem. 2005. PMID: 16302820

3

Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist.

Rosen TJ, Coffman KJ, McLean S, Crawford RT, Bryce DK, Gohda Y, Tsuchiya M, Nagahisa A, Nakane M, Lowe JA 3rd. Rosen TJ, et al. Among authors: nagahisa a. Bioorg Med Chem Lett. 1998 Feb 3;8(3):281-4. doi: 10.1016/s0960-894x(98)00012-2. Bioorg Med Chem Lett. 1998. PMID: 9871670

4

Aza-tricyclic substance P antagonists.

Lowe JA 3rd, Drozda SE, McLean S, Bryce DK, Crawford RT, Snider RM, Longo KP, Nagahisa A, Tsuchiya M. Lowe JA 3rd, et al. Among authors: nagahisa a. J Med Chem. 1994 Sep 2;37(18):2831-40. doi: 10.1021/jm00044a002. J Med Chem. 1994. PMID: 7520943

5

The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.

Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A. Lembeck F, et al. Among authors: nagahisa a. Br J Pharmacol. 1992 Mar;105(3):527-30. doi: 10.1111/j.1476-5381.1992.tb09013.x. Br J Pharmacol. 1992. PMID: 1378337 Free PMC article.

6

Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice.

Beierschmitt WP, McNeish JD, Griffiths RJ, Nagahisa A, Nakane M, Amacher DE. Beierschmitt WP, et al. Among authors: nagahisa a. Toxicol Sci. 2001 Sep;63(1):15-21. doi: 10.1093/toxsci/63.1.15. Toxicol Sci. 2001. PMID: 11509739

7

Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.

Tsuchiya M, Fujiwara Y, Kanai Y, Mizutani M, Shimada K, Suga O, Ueda S, Watson JW, Nagahisa A. Tsuchiya M, et al. Among authors: nagahisa a. Pharmacology. 2002 Nov;66(3):144-52. doi: 10.1159/000063796. Pharmacology. 2002. PMID: 12372904

8

Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist.

Nagahisa A, Kanai Y, Suga O, Taniguchi K, Tsuchiya M, Lowe JA 3rd, Hess HJ. Nagahisa A, et al. Eur J Pharmacol. 1992 Jul 7;217(2-3):191-5. doi: 10.1016/0014-2999(92)90847-w. Eur J Pharmacol. 1992. PMID: 1330589

9

Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist.

Nagahisa A, Kanai Y, Suga O, Taniguchi K, Tsuchiya M, Lowe JA 3rd, Hess HJ. Nagahisa A, et al. Regul Pept. 1993 Jul 2;46(1-2):440-3. doi: 10.1016/0167-0115(93)90113-m. Regul Pept. 1993. PMID: 7692561 No abstract available.

10

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.

McLean S, Ganong A, Seymour PA, Bryce DK, Crawford RT, Morrone J, Reynolds LS, Schmidt AW, Zorn S, Watson J, Fossa A, DePasquale M, Rosen T, Nagahisa A, Tsuchiya M, Heym J. McLean S, et al. Among authors: nagahisa a. J Pharmacol Exp Ther. 1996 May;277(2):900-8. J Pharmacol Exp Ther. 1996. PMID: 8627572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page